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Background: Chronic, non-healing wounds are often characterized by the persistence of bacteria within biofilms
- aggregations of cells encased within a self-produced polysaccharide matrix. Biofilm bacteria exhibit unique
characteristics from planktonic, or culture-grown, bacterial phenotype, including diminished responses to
antimicrobial therapy and persistence against host immune responses. Mesenchymal stromal cells (MSCs) are host cells
characterized by their multifunctional ability to undergo differentiation into multiple cell types and modulation of
host-immune responses by secreting factors that promote wound healing. While these characteristics make MSCs an
attractive therapeutic for wounds, these pro-healing activities may be differentially influenced in the context of an
infection (i.e., biofilm related infections) within chronic wounds. Herein, we evaluated the effect of soluble factors
derived from biofilms of clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa on the viability,
differentiation, and paracrine activity of human MSCs to evaluate the influence of biofilms on MSC activity in vitro.
Results: Exposure of MSCs to biofilm-conditioned medias of S. aureus and P. aeruginosa resulted in reductions in cell
viability, in part due to activation of apoptosis. Similarly, exposure to soluble factors from biofilms was also observed to
diminish the migration ability of cells and to hinder multi-lineage differentiation of MSCs. In contrast to these findings,
exposure of MSCs to soluble factors from biofilms resulted in significant increases in the release of paracrine factors
involved in inflammation and wound healing.
Conclusions: Collectively, these findings demonstrate that factors produced by biofilms can negatively impact the
intrinsic properties of MSCs, in particular limiting the migratory and differentiation capacity of MSCs. Consequently, these
studies suggest use/application of stem-cell therapies in the context of infection may have a limited therapeutic effect.
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Effective wound healing is a highly coordinated, multistage
process involving multiple host mechanisms, including in-
flammation, neovascularization, cell proliferation, extracel-
lular matrix formation, and cellular maturation and
remodeling. In contrast to acute wounds, which often heal* Correspondence: catherine.l.ward.vol@mail.mil
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primarily characterized by dysregulated inflammatory re-
sponses and cell defense mechanisms, which often result
in delayed and/or non-healing of the wound [1]. The pres-
ence of microorganisms within tissues is a major risk factor
for the development of chronic wounds. Recent studies
evaluating the biodiversity within various types of chronic
wounds demonstrated the presence of multiple species of
bacteria, including Staphylococcus aureus, Pseudomonashis is an Open Access article distributed under the terms of the Creative
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coccus spp [2,3]. In contrast to surviving in a predominately
planktonic form, such as in vitro cultures, bacteria adapt to
and persist within chronic wounds as a heterogeneous
population that is predominately attached to host tissues,
known as a biofilm [4,5]. To date numerous studies have
demonstrated the presence of bacterial biofilms in various
settings involving chronic human infections, indicating a
causal relationship between the presence of bacterial bio-
films and the development of these types of infection. For
example, in a sample of patients with chronic, non-healing
cutaneous wounds, over half were characterized as contain-
ing biofilm [4]. Similarly, recent reports evaluating non-
union of long bone fractures have also shown that the
presence of biofilms was frequently associated with non-
osseous union [6]. Although the precise mechanisms
through which biofilm bacteria contribute to and promote
wound chronicity is not completely understood, a few stud-
ies have demonstrated that soluble factors released from
the biofilm can negatively impact cell function [4,5,7]. Stud-
ies evaluating interactions between biofilm communities
and cells involved in wound healing will be central to fur-
ther our understanding of how these processes may be per-
turbed during infection.
Regenerative cells known as mesenchymal stem cells,
multipotent mesenchymal stromal cells, and marrow
stromal cells (hereafter referred to as “MSCs” [8]) con-
tribute to wound healing directly through differentiation
[9,10], and indirectly through the release of paracrine
factors, such as stromal derived factor 1 (SDF-1) [11,12]
and vascular endothelial growth factor (VEGF) [13].
Additionally, MSCs have also been shown to have anti-
microbial properties through activities mediated by the
release of the antimicrobial peptide LL-37 [14-16]. The
combined properties of MSCs make them a critical
element of intrinsic wound healing, and a highly attract-
ive candidate for cell based therapies for tissue repair
and regeneration. To date, numerous studies have evalu-
ated the potential therapeutic applications of MSCs for
tissue regeneration. However, the vast majority of these
studies have primarily utilized wound models that lack
an infectious component. This is a particularly import-
ant lapse, as the functional activity of MSCs may be al-
tered in the presence of inflammatory mediators
produced by the host as well as bacterial components
that may accumulate within a chronic wound. In sup-
port of this, recent studies have demonstrated differen-
tial effects to normal healing and differentiation of
MSCs in the presence of purified microbial cell wall
components (e.g., Gram-negative lipopolysaccharide
(LPS) and Gram-positive lipoteichoic acid, (LTA)) [17,18],
inflammatory cytokines [19], peripheral blood mononucle-
ated cells (PBMCs) [20], and heat-inactivated bacteria
[21]. Consequently, these studies indicate that the abilityof MSCs to promote healing can be negatively affected in
the context of the wound environment.
Given the importance of bacterial biofilms in the de-
velopment of chronic wounds, the ability of these commu-
nities to inhibit wound healing, and the likely interactions
with host cells such as MSCs, herein we evaluated the ef-
fect of soluble factors from biofilms of clinical isolates of
S. aureus and P. aeruginosa on the viability, differentiation,
and paracrine activity of human bone marrow stromal
cells (hBMSCs) in vitro.
Methods
hBMSCs and cell culture
Primary human bone marrow stromal cells (hBMSCs,
STEMCELL Technologies, Vancouver, Canada) were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco®, Life Technologies, Grand Island, NY) supple-
mented with 10% fetal bovine serum (FBS) and 10 U peni-
cillin mL−1 and streptomycin 10 μg mL−1 at 37°C in 5 %
CO2. For all studies described herein, hBMSCs between
passages 1–4 were used.
Bacterial strains and growth conditions
UAMS-1 (ATCC strain 49230) is a methicillin-susceptible
S. aureus clinical strain of the USA 200 clonal group and a
well characterized osteomyelitis isolate [22]. P. aeruginosa,
strain SAMMC-418, is a multidrug-resistant, pulsed-field
type 2, clinical wound isolate selected from a strain collec-
tion at the San Antonio Military Medical Center
(SAMMC, Ft. Sam Houston, TX) [23]. Both strains used
in this study have been previously characterized for bio-
film formation. Bacteria were cultured in Cation-Adjusted
Mueller Hinton Broth (MHB-II) or on blood agar plates
at 37°C.
Biofilm formation and preparation of biofilm-conditioned
media (BCM)
Biofilm formation and generation of conditioned media
were performed as previously described [24,25]. Briefly,
500 μL of a 1:100 dilution of overnight bacterial cultures
(~106 CFU/mL) were added to transwell tissue culture
inserts (0.4 μm pore size, Corning Inc, Corning, NY)
and grown under static conditions for 48 hr at 37°C.
Culture inserts were washed, placed into DMEM, and
maintained at 37°C for up to 4 days. BCM was collected
daily and replaced with fresh media. Consistent with
previous studies and to reduce variations between indi-
vidual collections of BCM, individual fractions were
pooled [24,25]. Pooled BCMs were filter-sterilized using
a 0.2 μm syringe filter (Fisher, Pittsburgh, PA) to remove
any bacteria, pH adjusted to 7.4, and stored at −80°C.
Sterility of collected BCM was assessed by spot plating
10 μL aliquots of BCM onto MHB-II plates and incubat-
ing the plates overnight at 37°C.
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To evaluate the relationship between bacteria within
biofilms and level of protein present within the condi-
tioned medias over time, biofilms of S. aureus UAMS-1
and P. aeruginosa SAMMC-418 were grown in trans-
wells as described above and viable bacteria along with
total protein within the collected medias were measured
daily for up to five days. Bacteria were enumerated by
removing the polycarbonate membrane of the transwell,
followed by sonication of the entire membrane in 1 mL
of PBS and enumeration by plating serial dilutions on
blood agar plates. Protein corresponding to the same
time point and within the media was quantified using a
bicinchonic acid (BCA) assay (Pierce, Rockford, IL) fol-
lowing the manufacturer’s protocol.
Preparation of planktonic-conditioned media (PCM)
Planktonic bacterial cultures of S. aureus and P. aeruginosa
were grown under conditions to produce similar cell dens-
ities of the biofilm cultures. Briefly, individual bacterial col-
onies from overnight plate cultures were inoculated into
MHB-II and grown to early stationary phase (~109 CFU/
mL). Following growth in liquid culture, bacteria were har-
vested by centrifugation and resuspended in sterile DMEM,
then incubated at 37°C with agitation for an additional
24 hr. Following overnight incubation, planktonic bacteria
were then harvested by centrifugation and the supernatants
were collected, filter sterilized and adjusted to pH 7.4 prior
to use in experimental assays. Similar to the BCM, the
PCM was spot plated onto MHB-II plates and incubated
overnight at 37°C to ensure sterility of supernatants.
Cell viability
Cells were seeded into 48-well plates (at 5 × 103 cells/
cm2), grown to ~50% confluence, and exposed to either
purified bacterial cell wall components, including lipotei-
choic acid (LTA) from Staphylococcus aureus or lipopoly-
saccharide (LPS) from Eschrichia coli 0111:B4 (Sigma
Aldrich, St. Louis, MO) at 10 μg/mL [26], PCM or BCM
of S. aureus and P. aeruginosa for up to 7 days in vitro. As
a control for the treatment groups, cell media supple-
mented with PBS at similar concentrations were used for
comparison (vehicle control). Viability was assessed for up
to 7 days post-exposure using a LIVE/DEAD© assay kit
(Life Technologies™, Grand Island, NY) by measuring
fluorescence at EX485nm/EM530nm using a microplate
reader (SPECTRAmax M2, Molecular Devices, Sunnyvale,
CA) per the manufacturer’s instructions. Cell viability was
expressed as a ratio of an untreated, media only, growth
control for each respective timepoint.
Measurement of Caspase-3/7 activity
Caspase-3/7 activity in hBMSCs following exposure to
BCM was determined using the SensoLyte™ HomogenousAFC Caspase-3/7 Assay Kit (AnaSpec, San Jose, CA) for
up to 7 days, as previously described [27]. Briefly, 25 μL of
cell media from BCM-exposed hBMSCs was combined
with the caspase-3/7 substrate solution to initiate an en-
zymatic reaction to cleave and generate a fluorophore.
Fluorescence was detected at EX380nm/EM500nm using a
microplate reader. Caspase activity, measured by released
caspase-3/7 found in the media, was expressed as a ratio
of an untreated growth control. As in viability experi-
ments, caspase activity was also evaluated in cells exposed
to vehicle control, purified cell wall components, and
PCM of both S. aureus and P. aeruginosa.
Western blot analysis
Protein analysis was performed on cell lysates of hBMSCs
exposed to BCM after 7 days in culture. Briefly, whole cell
lysates were prepared by lysing cells with CelLytic™ M
(Sigma-Aldrich, St. Louis, MO) followed by treatment
with protease inhibitor cocktail (Sigma-Aldrich). Triplicate
samples were pooled and concentrated using 3000
NMWL centrifugal devices (Millipore, Billerica, MA).
Total cellular protein was determined by bicinchoninic
acid (BCA) assay (Pierce). Whole cells lysates (20 μg) were
separated on a 3-8% Tris-Acetate gel (NuPAGE®, Life
Technologies, Grand Island, NY) and electrophoretically
transferred to nitrocellulose membranes. Membranes were
blocked with PBS containing 5% bovine serum albumin
(BSA) and 0.1% Tween-20 for 1 hr and incubated over-
night at 4°C with primary antibodies including; rabbit
anti-human caspase-3, rabbit anti-human adiponectin,
rabbit anti-human PPARγ, rabbit anti-human RUNX2,
(1:1000; Cell Signaling Technology®, Danvers, MA), goat
anti-human leptin, rat anti-human alkaline phosphatase
(ALP) (0.1 μg/mL, R&D Systems, Minneapolis, MN),
rabbit anti-human osteocalcin (OCN) (1:1000; abcam®,
Cambridge, MA) and mouse anti-human Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) antibody (1:500;
Millipore, Billerica, MA). Following incubation, mem-
branes were washed then incubated with the appropriate
HRP-conjugated secondary antibody (1:3000–1:5000) for
1 hr at room temperature for detection of the proteins by
chemiluminesence. Relative protein levels were deter-
mined by comparative densitometric analysis of western
blot bands using the Odyssey Fc system (LI-COR Biosci-
ences, Lincoln, NE). For each protein examined, the mem-
brane initially probed was stripped, and the amount of
actin was determined using antibodies against GAPDH.
Relative levels of protein were determined by dividing the
intensity of the tested protein band to that of GAPDH
within the same lane and membrane.
Adipogenic differentiation
Cells were cultured at 5 × 103 cells/cm2 in 24-well
plates and grown to ~80% confluence. For adipogenic
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plemented with isobutyl-methyl xanthine (50 mM),
indomethacin (200 μM), insulin (1 μM), and dexa-
methasone (0.1 μM) (Sigma-Aldrich, St. Louis, MO).
Differentiation control groups contained an equivalent
volume of unsupplemented DMEM (as a vehicle con-
trol) as BCM in the experimental groups. Cells were
cultured for up to 21 days, with fresh media changes
every 3–4 days. At days 7, 14 and 21, cells were fixed in
10% formalin, stained for 10–15 min at room
temperature with a working solution of Oil Red O stain
(0.0035 g/mL in isopropanol, diluted 6:4 in deionized
water), rinsed 3x with distilled water, and oil droplets
were visualized by light microscopy at 40x magnifica-
tion (Olympus IX71 microscope, Center Valley, PA). For
quantification of staining, Oil Red was extracted from
cells using 100% isopropanol and absorbance at 500 nm
was measured. Results were expressed as a ratio of an
undifferentiated growth control. Protein expression
levels of genes involved adipogenic differentiation, in-
cluding adiponectin, PPARγ, and leptin, was also per-
formed on hBMSCs after 7 days of differentiation by
western blot analysis as described above.
Osteogenic differentiation
For osteogenic differentiation, cells were cultured as
above in growth media supplemented with ascorbate-2
phosphate (50 μM), β-glycerolphosphate (10 mM), and
dexamethasone (0.1 μM) (Sigma-Aldrich, St. Louis,
MO). At days 7, 14 and 21, cells were fixed with 10%
formalin, stained with 2% w/v Alizarin Red S in deion-
ized water (pH 7.0) for 20 min, washed with PBS, and
calcium deposits were visualized by light microscopy at
40x magnification (Olympus IX71 microscope, Center
Valley, PA). For quantification of staining, Alizarin Red
was extracted from cells using 0.5 N HCl in 5% SDS so-
lution and absorbance at 415 nm was measured. Results
were expressed as a ratio of an undifferentiated growth
control. Protein expression levels of genes involved
osteogenic differentiation, including RUNX2, OCN, and
ALP, was also performed on hBMSCs after 7 days of dif-
ferentiation by western blot analysis as described above.
RNA extraction and quantitative real-time PCR (qRT-PCR)
RNA extraction and isolation from hBMSCs exposed to
BCM was performed as previously described [24]. First
strand synthesis of cDNA was achieved with SuperScript
III first-strand synthesis supermix with oligo-dT primers
(InvitrogenTM, Grand Island, NY) for each RNA sample
using a PTC-100 Thermal Cycler (GMI Inc, Ramsey,
MN). For genes of interest, quantitative real-time poly-
merase chain reaction (qRT-PCR) was performed using
a Bio-Rad C1000 system and analyzed using iQ5 soft-
ware (BioRad, Hercules, CA) using 10 ng of RNA perreaction. Primers utilized in this study for genes of inter-
est, including peroxisome proliferator-activated receptor
gamma (PPARγ), adiponectin, leptin, alkaline phosphat-
ase (ALP), runt-related transcription factor 2 (RUNX2),
and bone gamma-carboxyglutamic acid-containing pro-
tein (osteocalcin, OCN), were purchased from SABios-
ciences (Valencia, CA) and the amplification reactions
were performed using SYBR Green Super Mix (BioRad,
Hercules, CA) following the optimized conditions rec-
ommended by the manufacturer. Three independent
biological experiments with three technical replicates
were performed for each reaction. Transcript levels were
normalized to GAPDH mRNA. Relative expression levels
were calculated using the 2–ΔCt method [28]. Relative
fold differences in gene expression were calculated as a
ratio of the normalized values compared to relative gene
expression in undifferentiated controls.
Capillary tube formation assay
Angiogenesis, as determined by capillary tube formation
of hBMSCs, was assessed using a matrigel-based assay
as previously described [29]. Briefly, individual wells of a
48-well tissue culture plate were coated with 100 μL of
Matrigel (100 mg/mL, BD Biosciences, San Jose, CA)
and allowed to polymerize for 1 hr at 37°C. Cells were
seeded on top of the gels at 2 x 104 cells/well in 200 μL
of media containing BCM. At 2, 6, and 16 hours post-
exposure, six images per well were taken at 40× and 100×
magnification with an inverted microscope (Olympus
IX71 microscope, Center Valley, PA) to analyze the devel-
opment of capillary-like networks using phase contrast
microscopy. Image analysis was performed using Image J
V1.44p software (U. S. National Institutes of Health,
Bethesda, MD). Capillary tube formation was assessed at
each time point by counting the number of capillary-like
tubules and by measuring tube length (μm) between
connectors.
Cell migration
Functional migration analysis of hBMSCs was performed
using an Oris™ Cell Migration Assay-FLEX (Platypus
Technologies, Madison, WI) according to the manufac-
turer’s instructions. Briefly, cells were seeded into black
96-well clear bottom microplates (5 × 103cells/cm2) con-
taining a rubber stopper at the plate center, creating a
void circle (2 mm diameter) area. hBMSCs were grown
to ~80% confluence at which time the stoppers and
media were removed, and replenished with media con-
taining BCM. Positive control wells containing growth
media (0% BCM, with an equivalent volume of unsup-
plemented DMEM as the BCM experimental groups to
represent a vehicle control) and negative control wells
with stopper in place (depicting no migration) were
maintained in the well plate. Cells were allowed to
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were stained with Vybrant® CFDA SE Cell Tracer dye
(InvitrogenTM, Grand Island, NY). Wells were viewed at
40x magnification using an inverted microscope (Olym-
pus IX71 microscope, Center Valley, PA) with a FITC fil-
ter to image the entire area of migration. Using Adobe®
Photoshop® CS3 (San Jose, CA), images were converted
to black and white, and threshold was recorded. Quanti-
fication was performed by calculating a ratio based on
the threshold of the experimental well images to that of
a full growth control (i.e., 100% confluency). This ratio
was deemed as the amount of migration that occurred
into the void area over the course of 3 days.
Quantification of cytokines
Enzyme-linked immunosorbant assays (ELISAs) were
performed to quantify cytokines in culture supernatants
(media) from hBMSCs exposed to BCM for 1 and 3 days.
ELISA kits for Tumor necrosis factor α (TNF-α) (R&D
Systems, Minneapolis, MN), Interleukin-6 (IL-6) (R&D
Systems, Minneapolis, MN), stromal cell derived factor 1a
(SDF-1) (TSZ ELISATM, Framingham, MA), vascular
endothelial growth factor (VEGF) (Quantikine®, Minneap-
olis, MN), and human cathelicidin LL-37 (Hycult® Biotech,
Netherlands) were performed according to the manufac-
turer’s instructions. Briefly, supernatants (media) were col-
lected from individual wells containing hBMSCs exposed
to BCM at days 1 and 3 (0.5 mL volumes), treated with
protease inhibitor cocktail (Sigma-Aldrich, St. Louis MO),
and stored at −80°C until analysis. Total protein in sam-
ples was quantified using a BCA assay (Pierce). Cytokine
levels in supernatants were quantified by extrapolation
from standard curves generated using recombinant pro-
tein for each respective cytokine, and determined concen-
trations were normalized to total protein content in each
supernatant sample as determined by the BCA assay.
Statistical analysis
Statistical analysis was performed using one-way
ANOVA with a Tukey’s multiple comparison post hoc
test for comparisons between groups. P values of <0.05
were considered to be statistically significant. All assays
were performed in triplicate.
Results
Soluble factors from biofilms reduce the viability of
hBMSCs, in part due to the activation of apoptosis
Initial screening of the effect of soluble factors of biofilms
on cell viability, was performed by exposing hBMSCs to
biofilm factors of S. aureus and P. aeruginosa at increasing
concentrations (0, 5, 10, 25, 50, 75, and 100%) in cell
growth media for 24 hours. Based on these preliminary re-
sults, a concentration of 25% BCM was determined to
provide optimal conditions to test the effect of BCM onhBMSC function without substantial loss of viability (i.e.,
to maintain a testable population for extended periods of
time), and therefore this concentration was used through-
out all future studies (Additional file 1: Figure S1). Expos-
ure of hBMSCs to biofilm factors of S. aureus and P.
aeruginosa at 25% was observed to have differential effects
on cell viability during the 7 day exposure, as compared to
the untreated growth control group (Figure 1C-D). Of
note, no significant loss of cell viability was observed in
cells exposed to media supplemented with PBS at 25% (ve-
hicle control group) for up to 7 days, indicating that the
observed effect was not the direct result of nutrient deple-
tion but specific for the factors within the conditioned me-
dias. Biofilm-derived factors from P. aeruginosa were
observed to have an overall greater negative effect on cell
viability compared to factors derived from biofilms of S.
aureus, with significant loses in cell viability observed at 1,
3, and 7 days post-exposure compared to the untreated
growth controls. S. aureus BCM was only observed to
have a significant negative effect on cell viability after
7 days. These observed differences of the effect of BCMs
on cell viability may have been in part due to the differ-
ences in bacterial number observed within biofilms as well
differences in total protein content with the respective
BCMs (Figure 1A-B). In contrast to the effects of BCM on
hBMSCs, exposure to purified bacterial cell wall compo-
nents, including LTA and LPS, or the respective PCM of
S. aureus and P. aeruginosa were observed to only have a
moderate effect on cell viability (Figure 1C-D).
Consistent with the results from the viability assays,
cellular caspase 3/7 activity was observed to increase fol-
lowing exposure to BCM of both S. aureus and P. aeru-
ginosa at day 1 post exposure, and for P. aeruginosa at
days 1, 3 and 7, in part explaining the reduced cell num-
bers observed over time (Figure 2A-B). In support of
this, western blot analysis of activated caspase activity in
pooled cell lysates demonstrated elevated levels of cas-
pase in BCM-exposed groups (Figure 2C-D). As ob-
served in previous experiments, exposure of cells to
LTA, LPS, and the respective PCMs of both strains were
observed to have little to moderate effect on cell apop-
tosis compared to the BCM. Collectively these observa-
tions support the notion that biofilms release factors
that are not observed in the planktonic form, justifying
further analysis of the BCM on the activity of hBMSCs.
Multilineage differentiation potential of hBMSCs is
decreased in the presence of soluble factors from biofilms
A central feature of multipotent mesenchymal stromal cells
is their ability to undergo multilineage differentiation and
contribute to regeneration of injured tissues. In the pres-
ence of BCM from S. aureus and P. aeruginosa, the multili-
neage differentiation potential of hBMSCs was significantly
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Figure 1 Soluble factors from biofilms reduce viability in hBMSCs. Enumeration of viable bacteria within biofilms (A) and measurement of
released protein from biofilms (B) of S. aureus UAMS-1 and P. aeruginosa SAMMC-418 grown for up to 5 days. (C) Cell viability of hBMSCs over a
7 day period following exposure to media containing 25% PBS (vehicle control), lipoteichoic acid (LTA, 10 μg/mL at 25%, Gram-positive cell wall
component), S. aureus UAMS-1 planktonic-conditioned media (PCM), and S. aureus UAMS-1 biofilm-conditioned media (BCM). (D) Cell viability of
hBMSCs over a 7 day period following exposure to media containing 25% PBS (vehicle control), lipopolysaccharides (LPS, 10 μg/mL at 25%,
Gram-negative cell wall component), P. aeruginosa SAMMC-418 PCM, and P. aeruginosa SAMMC-418 BCM. Values are expressed as a ratio of the
untreated growth control (untreated hBMSCs exposed to complete growth media, indicated by dashed lines) and represent the average ± SEM.
*,#,+ p < 0.05 compared to day 1, 3 and 7 controls, respectively.
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were significantly impaired in their ability to differenti-
ate into mature adiopocytes and osteocytes compared
to the unexposed differentiation controls (Figure 3).
Visual examination of cells, as demonstrated in represen-
tative images, for presence of oil droplets and intracellular
calcium deposits, markers of adipogenic and osteogenic
differentiation, respectively, were reduced compared to
the differentiation control groups (Figure 3A and D).
Measurement of the ratio of solubilized oil red and ali-
zarin red to undifferentiated growth controls also demon-
strated decreases in cell differentiation (Figure 3B andE).
Consistent with this visual decrease in differentiation cap-
ability, independent gene (Tables 1 and 2) and protein
expression analysis (Figure 3C and F, Additional file 2:
Figure S2) of adipogenic and osteogenic markers also dem-
onstrated a reduced differentiation capacity of hBMSCs
following exposure to BCM.In congruence with their reduced adipogenic and
osteogenic differentiation, the ability of hBMSCs to form
capillary-like tubes was also inhibited in the presence of
biofilm-derived factors (Figure 4A-C). In contrast to the
untreated growth control group, which formed a stable
tube network characterized by dense tubules forming as
early as 6 hours on the gel matrices, hBMSCs exposed
to BCM were unable to form mature tubule networks
similar to that visualized for control groups within
16 hours (Figure 4A). Although, early exposures to
BCM exhibited comparable tube numbers to control
groups, as conventional stable networks formed with ef-
ficient merging in controls (no BCM exposure), net-
works with BCM exposure maintained a higher tube
number, suggesting that the networks failed to mature
at the expected rates (Figure 4B). Consistent with this,
cells exposed to BCM had significantly decreased aver-




































































































































Figure 2 Soluble factors from biofilms increase caspase activity in hBMSCs. (A) Caspase-3/7 activity of hBMSCs over a 7 day period following
exposure to media containing 25% PBS (vehicle control), lipoteichoic acid (LTA, 10 μg/mL at 25%, Gram-positive cell wall component), S. aureus UAMS-1
planktonic-conditioned media (PCM), and S. aureus UAMS-1 biofilm-conditioned media (BCM). (B) Caspase-3/7 activity of hBMSCs over a 7 day period
following exposure to media containing 25% PBS (vehicle control), lipopolysaccharides (LPS, 10 μg/mL at 25%, Gram-negative cell wall component),
P. aeruginosa SAMMC-418 PCM, and P. aeruginosa SAMMC-418 BCM. Values are expressed as a ratio of the untreated growth control (untreated hBMSCs
exposed to complete growth media, indicated by dashed lines) and represent the average ± SEM. *,#,+ p< 0.05 compared to day 1, 3 and 7 controls,
respectively. (C) Western blot analysis of Caspase-3 antibody on hBMSC lysates, illustrating the presence of the endogenous uncleaved form (35 kDa) and
the activated cleaved form (17-19 kDa). (D) Semiquantitative analysis of the ratio of activated (cleaved) to inactive (uncleaved) levels of caspase-3 as
determined by densitometric analysis. Protein levels were normalized to levels GAPDH probed on the same membrane. Staurosporine, an apoptic inducing
agent was included as a positive control for apoptosis.
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formation of established tube networks.
Migration of hBMSCs is hindered by the presence of
biofilm-derived factors
The ability of cells to migrate towards sites of injury is cen-
tral to enacting their roles during the wound healing
process. Using a void circle migration assay, the effect of
BCM on the migratory capacity of hBMSCs was assessed.
After 3 days, in the absence of BCM, cells were able to al-
most completely fill the void space in the standard migra-
tion assay (i.e. >80% confluence). In contrast, in the
presence of BCM from S. aureus and P. aeruginosa, the mi-
gration of hBMSCs was significantly impaired (Figure 4D),
with few to little cells migrating into the void space (i.e.
<10%). Quantification of the ratio of migration, as deter-
mined by measuring the cell amount within the void area,demonstrated that on average, the exposure to BCM re-
duced the migration capacity by > 6 fold compared to the
untreated growth control (Figure 4E).
hBMSCs enhance the production of inflammatory and
wound healing cytokines in response to soluble factors
from biofilms
MSCs modulate the wound environment through the re-
lease and activity of various cytokines. To evaluate the im-
pact of BCM on the paracrine activity of hBMSCs, the
levels of cytokines were quantified, including inflamma-
tory cytokines (TNF-α, IL-6), wound healing cytokines
(SDF-1, VEGF) and an antimicrobial peptide (LL-37) in
hBMSC supernatants following exposure to BCM. In the
presence of biofilm factors derived from S. aureus and P.
aeruginosa, TNF-α and IL-6 were significantly increased at
days 1 and 3 post-exposure compared to untreated control
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Figure 3 Soluble factors from biofilms differentially affect adipogenic and osteogenic differentiation of hBMSCs in vitro. A) Light
microscopy images of hBMSCs stained with Oil Red O (red, 40x magnification) after adipogenic differentiation on days 7, 14 and 21 in the
presence of BCM (25%) from S. aureus or P. aeruginosa. B) Quantification of Oil Red O stain (OD500nm) to detect intracellular oil droplets following
adipogenic differentiation determined by extraction and solubilization of the dye. C) Western blot analysis of adipogenic proteins: adiponectin,
peroxisome proliferator-activated receptor gamma (PPARγ), and leptin. D) Light microscopy images of hBMSCs stained with Alizarin Red S
(red, 40x magnification) after osteogenic differentiation on days 7, 14 and 21 in the presence of BCM (25%) from S. aureus or P. aeruginosa.
E) Quantification of Alizarin Red S stain (OD415nm) to detect intracellular calcium deposits following osteogenic differentiation. F) Western blot
analysis of osteogenic proteins: Runt-related transcription factor 2 (RUNX2), bone gamma-carboxyglutamic acid-containing protein (osteocalcin),
and alkaline phosphatase. Quantification results are expressed as a ratio of non-differentiated growth controls (dashed line) at each timepoint;
*p < 0.05 compared to differentiation control at each respective timepoint.
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larly, significant increases in the production of wound
healing cytokines, SDF-1, VEGF, and antimicrobial peptide
LL-37 by hBMSCs exposed to BCM were also observed
(Figure 5C-E, Additional file 3: Figure S3).Discussion
In response to injury, the recruitment of host MSCs and
their subsequent activity within wounds is a central part
in the healing process. MSCs participate in wound heal-
ing directly, through differentiation and replacement of
Table 1 Relative expression of genes involved in adipogenic differentiation
Day 3 Day 7
Relative expression Fold difference Relative expression Fold difference
PPARγ
Differentiation control 0.70 ± 0.37 14.45 0.11 ± 0.71 4.72
S. aureus UAMS-1 0.29 ± 0.26 6.02 0.19 ± 0.50 8.19
P. aeruginosa SAMMC-418 0.50 ± 0.29 10.31 0.20 ± 0.74 8.53
Adiponectin
Differentiation control 0.00 ± 1.42 0.96 0.24 ± 1.12 376.63
S. aureus UAMS-1 0.10 ± 1.35 147.34 0.01 ± 1.03 21.30
P. aeruginosa SAMMC-418 0.00 ± 1.36 0.98 0.00 ± 1.60 2.77
Leptin
Differentiation control 0.06 ± 1.02 0.22 0.90 ± 0.88 93.90
S. aureus UAMS-1 0.01 ± 1.01 0.05 0.03 ± 0.60 2.61
P. aeruginosa SAMMC-418 0.01 ± 1.00 0.04 0.00 ± 0.61 0.23
PPARγ – peroxisome proliferator-activated receptor gamma.
Values represent the mean ± SD relative expression of genes as determined by the 2-ΔCt method. Fold difference is the expression of normalized values as a ratio
to undifferentiated growth controls.
Ward et al. BMC Microbiology  (2015) 15:75 Page 9 of 14damaged tissues, and indirectly through paracrine activ-
ities, which can orchestrate a regenerative microenviron-
ment [30-34], and modulate host immune responses
[9,10,35]. However, within infected wounds, the persist-
ence of microbial pathogens, in addition to the dam-
aging environment caused by pathogen exposure, could
differentially affect the properties of MSCs. Indeed, re-
cent studies have demonstrated that the differentiation
capacity of MSCs can be modulated in an inflammatory
environment [36] as well as in the presence of purified
cell wall components of bacterial pathogens [18,20,21].




Differentiation control 13.11 ± 0.34 7.5
S. aureus UAMS-1 3.23 ± 0.25 1.8
P. aeruginosa SAMMC-418 0.53 ± 0.35 0.3
RUNX2
Differentiation control 0.53 ± 0.82 3.5
S. aureus UAMS-1 0.21 ± 0.99 1.4
P. aeruginosa SAMMC-418 0.13 ± 0.62 0.8
OCN
Differentiation control 0.34 ± 0.36 1.9
S. aureus UAMS-1 0.01 ± 0.35 0.0
P. aeruginosa SAMMC-418 0.02 ± 0.27 0.1
ALP – alkaline phosphatase; RUNX2 – Runt-related transcription factor 2; OCN – bo
Values represent the mean ± SD relative expression of genes as determined by the
to undifferentiated growth controls.interactions between MSCs and signals that would be
present in an infected wound environment, evaluation of
the effect of soluble factors of biofilms, the predominate
mode of growth within tissues, on MSCs has not been
previously reported.
Bacterial biofilms have been shown to directly disrupt
the normal wound healing process in vitro and in vivo
[37-40]. This is, in part, thought to be mediated through
the activity of soluble bacterial products released from
the biofilm on host cells. Recent studies comparing the
effects of biofilm to planktonic cultures have shown that
biofilms can induce distinctive inflammatory responsesifferentiation
Day 7
ld difference Relative expression Fold difference
1 7.69 ± 0.51 14.55
5 0.27 ± 0.38 0.52
0 0.07 ± 0.45 0.13
4 0.91 ± 0.72 2.59
2 1.24 ± 0.70 3.56
5 1.35 ± 0.67 3.86
2 31.91 ± 0.53 10.42
8 0.01 ± 0.86 0.00
2 0.00 ± 0.52 0.00
ne gamma-carboxyglutamic acid-containing protein (osteocalcin).
2-ΔCt method. Fold difference is the expression of normalized values as a ratio
Growth Control
P. aeruginosa SAMMC-418Negative Control



















































































































Figure 4 Tube formation and migratory function of hBMSCs are differentially affected by the presence of soluble factors of biofilms.
A) Representative light microscopy images of hBMSCs after 2, 6 and 16 h of angiogenic differentiation on gel matrices (40x magnification) in
the presence of BCM (25%) from S. aureus and P. aeruginosa. B) Quantification of capillary-like tube number and C) tube length (μm) between
connectors using Image J software (n = 6 images per group).* p < 0.05 compared to growth control at each timepoint. D) Representative fluorescent
microscopy images of hBMSCs stained with Vybrant® CFDA SE Cell Tracer dye (green, 40x magnification) after 3 days of migration into void area in the
presence of BCM (25%) from S. aureus and P. aeruginosa. E) Quantification of cell migration into void area based on measurement of fluorescence and
image thresholding, using Image J software; *p < 0.05 compared to growth control.
Ward et al. BMC Microbiology  (2015) 15:75 Page 10 of 14and differentially activate apoptosis in human cell lines
[25,41]. Similarly, exposure of osteoblasts to soluble bio-
film products resulted in increased apoptosis, decreased
osteogenesis and enhanced release of factors promoting
bone resorption [24]. Prior to the current study, the ef-
fect of biofilms on hBMSCs had not been studied. The
present study showed early and pronounced negative ef-
fects on hBMSC viability along with increases in caspase
activity following exposure to soluble factors from bio-
films of S. aureus and P. aeruginosa. Comparisons of
planktonic versus biofilm conditioned medias have dem-
onstrated that there is a substantial overlap between the
extracellular proteomes, with only a small minority ofproteins unique to either phenotype [24,25,42]. Because
biofilms are heterogeneous in their composition, having
bacteria in the planktonic and biofilm state, the observed
effects on hBMSCs are likely due to the cumulative ef-
fect of released proteins within conditioned medias
expressed by both phenotypes, such as exoenzymes and
exotoxins [24]. Future studies evaluating the soluble fac-
tors released by biofilms of these different bacterial spe-
cies may provide further insight into the identity of
these soluble factors as well as providing potential
mechanisms for the loss of cell viability. Interestingly,
exposure of hBMSCs to BCM of P. aeruginosa was ob-
served to be much more toxic to cells compared to the








































































































Figure 5 Soluble factors from biofilms increase release of wound healing cytokines from hBMSCs. Quantification of inflammatory
cytokines TNF-α (A) and IL-6 (B), wound healing cytokines SDF-1 (C) and VEGF (D), and antimicrobial peptide LL-37 (E) in cell supernatants
(media) by ELISA analysis following hBMSC exposure to BCM (25%) for 1 and 3 days. Protein levels were normalized, expressed as a ratio of
specific cytokine concentration to total protein content (μg/mL, quantified via a bicinchoninic acid assay); *,# p < 0.05 compared to day 1 and 3
growth control, respectively.
Ward et al. BMC Microbiology  (2015) 15:75 Page 11 of 14conditioned media of S. aureus. Evaluation of viable bac-
teria within and released protein during biofilm growth
revealed only moderate differences between the two
strains, indicating that the observed differences on cell
viability may not have been the result of higher protein
concentrations or bacterial numbers within the biofilm,
but due to differences in the factors expressed by the
two bacterial species.
In addition to decreased cell viability, successful direct
functional differentiation processes of MSCs were also
significantly decreased in the presence of BCM. Specific-
ally, the processes of adipogenesis (defined by transcrip-
tional factors PPARγ, adiponectin, and leptin, which are
either regulators of adipocyte differentiation or secreted
by mature adipocytes) and osteogenesis (defined by tran-
scriptional factors RUNX2, ALP and OCN, which are es-
sential for osteoblast differentiation, matrix elaboration,
and bone mineralization and calcium ion homeostasis, re-
spectively) were severely disrupted by the factors associ-
ated with both Gram-negative and Gram-positive bacterial
biofilms. Further, functional assays supported this finding,
showing little to no oil droplet formation or calcium de-
position for cells undergoing adipogenesis and osteogen-
esis in the presence of BCM, respectively. Conversely, a
previous study demonstrated that exposure of adipose-
derived MSCs to heat-inactivated Gram-negative bacteria
and LPS induced osteogenic differentiation but reduced
adipogenic differentiation. Heat-inactivated Gram-positivebacteria showed similar results, while LTA had no impact
on the cells [21]. In the current study, the loss in func-
tional differentiation occurred with exposure to BCM of
both strains, suggesting that the soluble products within
the conditioned medias at the concentrations tested re-
duced the regeneration effects of MSCs. Although loss of
cell viability may in part explain the reduced differenti-
ation capacity of hBMSCs, use of multiple independent
analysis requiring normalization of the data herein indi-
cate a specific effect following treatment with BCM inde-
pendent of cell loss.
Cellular migration and angiogenesis were assessed in
the presence of BCM. Previous studies have observed in-
creased cellular migration towards areas of S. aureus–in-
fected cells [43] and increased cellular tube formation in
the presence of bacteria [44], suggesting infectious patho-
gens promote migratory and angiogenic mechanisms of
healing due to activation of the NF-κB pathway. Our re-
sults, however, indicate that migration, via a wound healing
assay, and angiogenesis, via a tube formation assay, were
significantly decreased with S. aureus and P. aeruginosa
BCM present compared to growth controls. The explan-
ation for this may possibly be due to the BCM pathogen-
induced activation of specific toll-like receptors (TLRs).
TLRs of MSCs have been identified as the recognition sites
of bacterial structures, also known as pathogen-associated
molecular patterns (PAMPs) [45,46]. For example, TLR4
is a receptor for LPS and TLR2 can bind bacterial
Ward et al. BMC Microbiology  (2015) 15:75 Page 12 of 14lipoproteins. TLRs have been shown to affect proliferation
and drive the critical stress responses of MSCs as well as
disrupt normal differentiation pathways. In a recent study,
MSCs that were treated with various TLR ligands showed
induction of certain cytokines and chemokines, including
TNF-α, chemokine ligand CCL2, CXCL10 interferon-
gamma-inducible protein (IP10), IL-6, IL-8, interferon
(IFN)1β, and NF-κB [17]. Futhermore, TLR stimulation also
triggered enhanced migration of MSCs [47]. Activation of
TLR3 in MSCs induced the release of trophic factors (IL-6,
SDF-1, hepatocyte growth factor and VEGF), but inhibited
proliferation and migration [48]. Identifying these distinct
recognition pathways have led to the theory that MSCs can
be polarized by downstream TLR signaling to a series of
specific phenotypes, including a pro-inflammatory pathway
(TLR4 initiated), or an immunosuppressive pathway (TLR3
initiated) [36]. The likely presence of multiple factors, rep-
resentative of the planktonic and biofilm phenotypes,
within the BCM suggests the possibility of TLR activation
in MSCs, although the decrease in viability/proliferation
with BCM may be adding a confounding factor that virtu-
ally eliminates healing functions. Future studies evaluating
the role of TLRs in these processes are required to deter-
mine the exact mechanisms of action.
Despite functional assessments being hindered, trophic
factors of hBMSCs in the presence of BCM were ana-
lyzed to determine if the innate healing cascade was acti-
vated during initial BCM exposure. MSC phenotype fate
can be determined with minimal exposure to pathogens/
agonists, with studies suggesting that as little as a one
hour exposure can initiate changes, which has been used
to mimic the gradient of danger signals that endogenous
MSCs encounter and respond to at a distance from the
injury site [36]. The present study provided a continuous
exposure to soluble biofilm products to more closely
mimic the clinical setting of pathogens in a wound. Ini-
tial exposure was assessed for the early onset of cellular
death or phenotypic change, based on release of inflam-
matory cytokines and upregulation of wound healing
and antimicrobial cytokines. TNF-α and IL-6, both cyto-
kines suggestive of a distressed, pro-inflammatory envir-
onment, were upregulated in the presence of BCM.
TNF-α is a key regulator of the NF-κB pathway, which,
as mentioned previously, regulates genes that influence
migration, proliferation, differentiation and inflamma-
tion. Interestingly, TNF-α has been shown to stimulate
MSC proliferation through the upregulation of cyclin D
[49]; however, a severe decrease in proliferation and via-
bility was observed after exposure to BCM even though
TNF-α was significantly increased. IL-6 expression in
cells, which typically exhibits immunomodulatory
[45,50] and anti-inflammatory [51] responses, was simi-
larly upregulated in hBMSCs in the presence of BCM.
Previous reports demonstrate SDF-1 upregulation duringinflammation processes in MSCs [11,12,52]. Our results
illustrate that in the presence of soluble factors from
biofilms, there was a significant increase in secreted
SDF-1 protein. Secretion of VEGF, an important factor
for mediation of angiogenesis, is increased in MSCs
(specifically, adipose-derived stem cells) which were ex-
posed to wound exudates [13]. This process is part of a
healing cascade during which MSCs exhibit angiogenic
potential during inflammatory processes to contribute to
oxygenation of a wound [53]. The exposure of hBMSCs
to BCM provided a similar result, with increased se-
creted VEGF. Human cathlicidin antimicrobial peptide
hCAP-18/LL-37 has been identified as one of the factors
that defines the antimicrobial activity of MSCs [54]. The
exposure of hBMSCs to BCM significantly increased the
levels of secreted LL-37, suggesting that initial short-
term presence of soluble factors from biofilms allowed
for anticipated increases in antimicrobial activity. The
assessment of these mediators indicates that the healing
signals of hBMSCs followed the expected inflammatory
responses according to the paracrine activity assessed.
Conclusions
Collectively this study demonstrates that in the presence of
soluble factors released by biofilms, the regenerative
capacity of MSCs is hindered or lost, while maintaining a
secretory phenotype. The main findings of this study are
that soluble factors released by mature biofilms of clinically
relevant pathogens can induce initial inherent healing path-
ways; however, there is a negative impact on the viability of
MSCs partially by induction of apoptosis, a hindrance of
healing mechanisms of migration and angiogenesis, and in-
complete multi-differentiation potential. The combination
of these responses to biofilms gives insight to the non-
healing aspect of chronic wounds, which typically have a
strong biofilm presence; furthermore, these facts indicate
that the use of cell-based therapies for the treatment of
chronic wounds may have a less than desired effect for tis-
sue regeneration in the context of infection. Future work
may include the elucidation of the mechanisms of action of
biofilms on MSCs to develop optimized therapies allowing
MSCs to function in the presence of infection.Additional files
Additional file 1: Figure S1. Concentration dependent effect of biofilm
factors on hBMSC viability. (A) Cell viability (performed via a LIVE/DEAD©
assay kit) of hBMSCs following 24-hr exposure to supplemented DMEM
containing increasing concentrations (0-100%) PBS (vehicle control),
S. aureus UAMS-1 biofilm-conditioned media (BCM), or P. aeruginosa
SAMMC- 418 biofilm-conditioned media (BCM). Dashed line represents
viability of untreated growth control. (B) Representative fluorescent
images of viable hBMSCs following exposure to increasing concentrations
of BCM after 24 hours, stained with calcein (green, 40x magnification).
Losses in viability became noticeably evident at 50% (after 24-hr
Ward et al. BMC Microbiology  (2015) 15:75 Page 13 of 14exposure) and therefore, 25% BCM was used in all future studies to assess
hBMSC function without a substantial loss of viability.
Additional file 2: Figure S2. Quantification of adipogenic and
osteogenic differentiation proteins of hBMSCs following exposure to
soluble biofilm factors. Protein was isolated and quantified from pooled
(n = 3) lysates of cultured hBMSCs that were exposed to soluble biofilm
factors from S. aureus UAMS-1 and P. aeruginosa SAMMC-418 under
adipogenic (A) and osteogenic (B) conditions. Cells were exposed for 7
days. Under adipogenesis, adiponectin, PPARγ and leptin proteins were
analyzed and expression was normalized to GAPDH. Under osteogenesis,
RUNX2, osteocalcin and ALP were analyzed and expression was normalized
to GAPDH. All differentiation proteins were lower in samples that were
exposed to biofilm factors in comparison to differentiation controls,
regardless of whether cells were undergoing adipogenesis or osteogenesis.
Additional file 3: Figure S3. Cytokine concentrations released from
hBMSCs following biofilm factor exposure. Cytokine levels were
calculated based on ELISA analysis of an aliquot of media (total volume
0.5mL supernatant) taken from cells exposed to BCM. Values obtained
were correlated to a standard curve of known concentrations provided
by the manufacturers for each respective cytokine. Absolute values from
cell monolayers and normalized values (to total protein content) are
presented. Fold increases above normalized growth control values at
each timepoint were calculated.
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